[The effects of PDK1-Akt signaling pathway intervention on cardiomyocyte HCN4 ion channels]

Z L Han1, X Wu1, X H Liu1

  • 1Department of Cardiology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China.

Insights

The 3-phosphate dependent protein kinase 1-protein kinase B (PDK1-Akt) pathway regulates cardiac hyperpolarized activated cyclic nucleotide gated 4 (HCN4) ion channels. Inhibiting PDK1 increases HCN4 expression and function, while activating Akt partially reverses this effect.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Ion Channel Physiology

Background:

  • Cardiac hyperpolarized activated cyclic nucleotide gated 4 (HCN4) ion channels are crucial for heart rhythm.
  • The 3-phosphate dependent protein kinase 1-protein kinase B (PDK1-Akt) signaling pathway plays a role in cellular processes.
  • Understanding the regulation of HCN4 channels is important for cardiac electrophysiology.

Purpose of the Study:

  • To investigate the role of the PDK1-Akt signaling pathway in regulating HCN4 ion channel transcription, expression, and function.
  • To elucidate the molecular mechanisms underlying PDK1-Akt pathway involvement in HCN4 channel modulation.

Main Methods:

  • Utilized wild-type and heart-specific PDK1 knockout mice atrial myocytes.
  • Employed techniques including qRT-PCR, Western blot, whole-cell patch clamp, and immunofluorescence.
  • Manipulated PDK1 levels via short hairpin RNA (shRNA) and modulated Akt activity using SC79 agonist and GSK2334470.

Main Results:

  • PDK1 knockout and knockdown significantly increased HCN4 mRNA and protein expression, as well as HCN current density.
  • Activation of Akt with SC79 partially reversed the effects of PDK1 knockdown on HCN4 expression and function.
  • GSK2334470 treatment also led to increased HCN4 expression.

Conclusions:

  • The PDK1-Akt signaling pathway is a key regulator of HCN4 ion channel transcription, expression, and function in atrial myocytes.
  • Modulation of this pathway offers potential therapeutic targets for cardiac rhythm disorders.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
331
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
198
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
229
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.3K